2020, Electronics, Provider and Telehealth

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2020

Electronics

Provider

Telehealth

Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall

Physician's Weekly

JUNE 17, 2025

TUESDAY, June 17, 2025 (HealthDay News) — Receipt of a stimulant prescription for attention-deficit/hyperactivity disorder (ADHD) via telehealth is not associated with an increased risk for substance use disorder (SUD), according to a study published online June 11 in The American Journal of Psychiatry. Vinod Rao, M.D., Vinod Rao, M.D.,

Telehealth

Telehealth Relationship Hospital Appointment

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

FDA Law

MAY 4, 2023

In a DCT, trial-related activities may occur in trial participants’ homes, at local health care providers’ offices, or in local clinical laboratories. This draft guidance builds on recommendations that FDA initially developed early in 2020, in response to the COVID-19 challenges (see our blog post on these recommendations here ).

Clinic

Clinic Telehealth Provider Electronics

Primary Care Digest

Prescribing ADHD Meds by Telehealth Does Not Alter Risk for Substance Use Disorder Overall

Clinical Trials Join the Remote Work Revolution: FDA’s New Draft Guidance on Decentralized Clinical Trials

Stay Connected